Get started
Author

María Soledad Undurraga

Observed names: M S Undurraga, M.S. Undurraga, Maria S. Undurraga, Maria Soledad Undurraga, Maria Undurraga, María S. Undurraga, María Soledad Undurraga S, Soledad S. Undurraga, Soledad Undurraga
Observed institution: Hospital del Salvador
ORCID: 0009-0001-3366-946X
Observed ORCID: 0009-0001-3366-946X
OpenAlex ID: A5004110875
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)
2011 · Hagop M. Kantarjian, Neil P. Shah, et al. · Blood · 616
PDF
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
2013 · Eduardo M. Rego, Haesook T. Kim, et al. · Blood · 152
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study
2014 · Antonio R. Lucena-Araujo, Haesook T. Kim, et al. · Annals of Hematology · 79
Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel
2021 · Carolina Pavlovsky, Virginia Abello Polo, et al. · Blood Advances · 44
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies
2015 · on behalf of the IC-APL and PETHEMA and HOVON Groups, Miguel A. Sanz, et al. · Annals of Hematology · 43
Myelodysplastic syndromes in S outh A merica: A multinational study of 1080 patients
2015 · Carolina B. Belli, Ronald Feitosa Pinheiro, et al. · American Journal of Hematology · 21
PDF
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia
2024 · Luísa Corrêa de Araújo Koury, Haesook T. Kim, et al. · Blood · 19
Long-Term Results from the Optic Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib
2023 · Jorge Cortes, Michael Deininger, et al. · Blood · 13
Post Hoc Analysis of Responses to Ponatinib in Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) By Baseline BCR-ABL1 Level and Baseline Mutation Status in the Optic Trial
2021 · Michael W. Deininger, Jane F Apperley, et al. · Blood · 8
Características citogenéticas y detección de anormalidades de alto riesgo en mieloma múltiple
2019 · María Eugenia Legües, Paulina Morales, et al. · Revista médica de Chile · 6
PDF
5-Year Follow-up of the Phase 2 Optic Study in Patients with Chronic-Phase Chronic Myeloid Leukemia: Efficacy, Safety, and First End-of-Treatment Mutational Results
2024 · Jorge E. Cortes, Michael W. Deininger, et al. · Blood · 5
PDF
Myelodysplastic syndromes in Latin America: state of the art
2018 · Renée Crisp, Sofía Grille, et al. · Blood Advances · 5
PDF
Cytogenetic and molecular characteristics of 25 Chilean patients with a variant Ph translocation
2011 · Maria E. Legues, Andrea Encina, et al. · Cancer Genetics · 5
Neutropenia febril de alto riesgo en leucemia aguda. Experiencia en un hospital público: Programa Nacional de Drogas Antineoplásicas del Adulto (PANDA), Hospital del Salvador, 1991-2001
2003 · Bárbara Puga L, Ismael Puga R, et al. · Revista médica de Chile · 4
PDF
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-trans retinoic acid
2024 · Wellington F. Silva, Haesook T. Kim, et al. · Haematologica · 3
PDF
Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en Chile
2001 · María Elena Cabrera C, Myriam Campbell B, et al. · Revista médica de Chile · 3
Outcomes and cause-specific mortality of AML in adults from Chile
2025 · Macarena Roa, Andres Ramirez, et al. · Blood · 2
PDF
Leucemia mieloide aguda del adulto: Resultados del Protocolo Nacional de Drogas Antineoplásica. Hospital del Salvador 1990-1998
2000 · Barbara Puga L, María Elena Cabrera C, et al. · Revista médica de Chile · 2
[Results of the National Protocol for Antineoplastic Drugs in the treatment of adult acute lymphoblastic leukemia. Experience at the Hospital del Salvador, 1990-1997].
1998 · B Puga, M E Cabrera, et al. · PubMed · 2
Características clínicas y epidemiológicas de las neoplasias mieloproliferativas Philadelphia negativas en el sistema público de salud de Chile
2021 · Ximena Valladares, Rafael Benavente, et al. · Revista médica de Chile · 1
Características clínicas y epidemiológicas de las neoplasias mieloproliferativas Philadelphia negativas en el sistema público de salud de Chile
2021 · Ximena Valladares, Rafael Benavente, et al. · Revista médica de Chile · 1
PDF
Hipercalcemia, peak monoclonal y leucemización como presentación de un linfoma de células B de alto grado, con reordenamiento de MYC, BCL-2 y BCL-6 (Triple Hit). Caso clínico
2017 · Camila Peña, María José Marti, et al. · Revista médica de Chile · 1
PDF
Leucemia prolinfocítica T variante de células cerebriformes: Presentación de un caso y revisión de la literatura
2016 · Camila Peña, Ximena Valladares, et al. · Revista médica de Chile · 1
PDF
Is EUTOS Score Predictive Of Outcome In Patients With Early Chronic Phase Chronic Myeloid Leukemia Treated With Imatinib? Preliminary Data From The National Protocol Of The Chilean Cooperative Group Panda
2013 · Javier Zelada, Marisa Pia Aida Capurro, et al. · Blood · 1
Leucemia promielocítica aguda: Resultados del protocolo terapéutico LPA2000, Programa Nacional de Cáncer del Adulto (PANDA), Ministerio de Salud, Chile
2013 · María Soledad Undurraga, Bárbara Puga, et al. · Revista médica de Chile · 1
PDF
Works count: 32
Citation count: 1,038
H-index: 8
I10-index: 8
Year
Topic
Type